S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
BAC   33.54 (-1.70%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
BAC   33.54 (-1.70%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
BAC   33.54 (-1.70%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
BAC   33.54 (-1.70%)
GILD   63.15 (-1.24%)
Log in

Alpine Immune Sciences News Headlines (NASDAQ:ALPN)

$3.43
+0.20 (+6.19 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
$3.25
Now: $3.43
$3.50
50-Day Range
$2.95
MA: $3.65
$4.40
52-Week Range
$2.25
Now: $3.43
$8.24
Volume28,549 shs
Average Volume14,526 shs
Market Capitalization$63.76 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

Headlines

Alpine Immune Sciences (NASDAQ ALPN) News Headlines

Source:
DateHeadline
Alpine Immune Sciences up 8% premarket on encouraging data on lead candidateAlpine Immune Sciences up 8% premarket on encouraging data on lead candidate
seekingalpha.com - January 24 at 4:31 PM
Alpine Immune Sciences Presents New Preclinical Data at 2020 Crohn’s & Colitis Congress  
ALPN-101 demonstrates efficacy in treatment of chronic inflammatory bowel disease in both in vivo and in vitro modelsAlpine Immune Sciences Presents New Preclinical Data at 2020 Crohn’s & Colitis Congress   ALPN-101 demonstrates efficacy in treatment of chronic inflammatory bowel disease in both in vivo and in vitro models
finance.yahoo.com - January 24 at 8:49 AM
Critical Review: Alpine Immune Sciences (NASDAQ:ALPN) versus Advanz Pharma (NASDAQ:CXRXF)Critical Review: Alpine Immune Sciences (NASDAQ:ALPN) versus Advanz Pharma (NASDAQ:CXRXF)
www.americanbankingnews.com - January 17 at 9:46 PM
 Brokerages Expect Alpine Immune Sciences Inc (NASDAQ:ALPN) Will Announce Quarterly Sales of $280,000.00 Brokerages Expect Alpine Immune Sciences Inc (NASDAQ:ALPN) Will Announce Quarterly Sales of $280,000.00
www.americanbankingnews.com - January 15 at 3:32 AM
Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares This Year?Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares This Year?
finance.yahoo.com - January 14 at 8:19 AM
Zacks: Brokerages Expect Alpine Immune Sciences Inc (NASDAQ:ALPN) Will Post Earnings of -$0.55 Per ShareZacks: Brokerages Expect Alpine Immune Sciences Inc (NASDAQ:ALPN) Will Post Earnings of -$0.55 Per Share
www.americanbankingnews.com - January 13 at 2:34 PM
Alpine Immune Sciences Announces Poster Presentation at 2020 Crohn’s & Colitis CongressAlpine Immune Sciences Announces Poster Presentation at 2020 Crohn’s & Colitis Congress
finance.yahoo.com - January 6 at 9:53 AM
Is Alpine Immune Sciences, Inc. (ALPN) A Good Stock To Buy?Is Alpine Immune Sciences, Inc. (ALPN) A Good Stock To Buy?
finance.yahoo.com - December 22 at 5:20 PM
Alpine Immune Sciences Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at the 61st American Society of Hematology Annual MeetingAlpine Immune Sciences Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at the 61st American Society of Hematology Annual Meeting
finance.yahoo.com - December 9 at 8:37 AM
Alpine Immune Sciences to Participate in Fireside Chat at 31st Annual Piper Jaffray Healthcare ConferenceAlpine Immune Sciences to Participate in Fireside Chat at 31st Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 26 at 10:32 AM
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2019 Results - Earnings Call TranscriptAlpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 12:59 AM
Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2019 Financial ResultsAlpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 13 at 7:58 PM
Alpine Immune Sciences Presents New ALPN-101 Preclinical Data at the 2019 American College of Rheumatology (ACR) Annual MeetingAlpine Immune Sciences Presents New ALPN-101 Preclinical Data at the 2019 American College of Rheumatology (ACR) Annual Meeting
finance.yahoo.com - November 12 at 12:29 PM
Alpine Immune Sciences Presents New Preclinical Data at The Society for Immunotherapy of Cancers (SITC) 34th Annual MeetingAlpine Immune Sciences Presents New Preclinical Data at The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting
finance.yahoo.com - November 8 at 8:23 AM
Alpine Immune Sciences Announces Oral Presentation of ALPN-101 at the 61st American Society of Hematology Annual Meeting and ExpositionAlpine Immune Sciences Announces Oral Presentation of ALPN-101 at the 61st American Society of Hematology Annual Meeting and Exposition
finance.yahoo.com - November 6 at 1:28 PM
Alpine Immune Sciences Completes Enrollment of Phase I Study of ALPN-101 and Announces Third Quarter Conference CallAlpine Immune Sciences Completes Enrollment of Phase I Study of ALPN-101 and Announces Third Quarter Conference Call
finance.yahoo.com - October 30 at 8:58 AM
Do Institutions Own Shares In Alpine Immune Sciences, Inc. (NASDAQ:ALPN)?Do Institutions Own Shares In Alpine Immune Sciences, Inc. (NASDAQ:ALPN)?
finance.yahoo.com - October 20 at 2:11 PM
Alpine Immune Sciences Announces Upcoming Scientific Presentations at SITC and ACR/ARHP 2019 Annual MeetingsAlpine Immune Sciences Announces Upcoming Scientific Presentations at SITC and ACR/ARHP 2019 Annual Meetings
finance.yahoo.com - October 2 at 9:21 AM
Alpine Immune Sciences to Present at 2019 Ladenburg Thalmann Healthcare ConferenceAlpine Immune Sciences to Present at 2019 Ladenburg Thalmann Healthcare Conference
finance.yahoo.com - September 18 at 3:27 AM
Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?
finance.yahoo.com - August 21 at 7:41 PM
Alpine Immune Sciences Provides Pipeline Update and Reports Second Quarter 2019 Financial ResultsAlpine Immune Sciences Provides Pipeline Update and Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 13 at 10:34 AM
Investors Who Bought Alpine Immune Sciences (NASDAQ:ALPN) Shares A Year Ago Are Now Down 43%Investors Who Bought Alpine Immune Sciences (NASDAQ:ALPN) Shares A Year Ago Are Now Down 43%
finance.yahoo.com - June 23 at 5:24 PM
Introducing Alpine Immune Sciences (NASDAQ:ALPN), The Stock That Dropped 43% In The Last YearIntroducing Alpine Immune Sciences (NASDAQ:ALPN), The Stock That Dropped 43% In The Last Year
finance.yahoo.com - June 23 at 5:24 PM
Alpine Immune Sciences Appoints Biopharma Veteran Wayne Gombotz as Chief Technology OfficerAlpine Immune Sciences Appoints Biopharma Veteran Wayne Gombotz as Chief Technology Officer
finance.yahoo.com - June 3 at 9:27 AM
Alpine Immune Sciences to Present at Upcoming Investor ConferencesAlpine Immune Sciences to Present at Upcoming Investor Conferences
finance.yahoo.com - May 24 at 9:38 AM
AdaptImmune partners to advance promising cancer immunotherapiesAdaptImmune partners to advance promising cancer immunotherapies
finance.yahoo.com - May 15 at 6:47 PM
Alpine Immune Sciences misses by $0.01Alpine Immune Sciences misses by $0.01
seekingalpha.com - May 9 at 9:32 AM
Earnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to DeclineEarnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to Decline
finance.yahoo.com - May 6 at 6:29 PM
Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares?Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares?
finance.yahoo.com - April 24 at 5:34 PM
Alpine Immune Sciences Appoints Stanford Peng to President and Head of Research and DevelopmentAlpine Immune Sciences Appoints Stanford Peng to President and Head of Research and Development
finance.yahoo.com - April 18 at 9:48 AM
The Zacks Analyst Blog Highlights: CMS Energy, Alpine Immune Sciences, Kohl's, Franklin Resources and Dominion EnergyThe Zacks Analyst Blog Highlights: CMS Energy, Alpine Immune Sciences, Kohl's, Franklin Resources and Dominion Energy
finance.yahoo.com - April 11 at 6:27 PM
Will Nivalis Therapeutics Continue to Surge Higher?Will Nivalis Therapeutics Continue to Surge Higher?
finance.yahoo.com - April 5 at 8:54 AM
Alpine Immune Sciences IncAlpine Immune Sciences Inc
www.bloomberg.com - March 19 at 9:50 AM
Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial ResultsAlpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial Results
finance.yahoo.com - March 18 at 9:18 AM
Alpine Immune Sciences: A New Name On The RadarAlpine Immune Sciences: A New Name On The Radar
seekingalpha.com - March 8 at 6:29 PM
Alpine Immune Sciences Presents Preclinical ALPN-101 GvHD Data at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT Meetings)Alpine Immune Sciences Presents Preclinical ALPN-101 GvHD Data at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT Meetings)
finance.yahoo.com - February 19 at 9:55 AM
Alpine Immune Sciences Announces First Subjects Dosed in Phase I Clinical Trial for Lead Autoimmune/Inflammatory Disease Program ALPN-101Alpine Immune Sciences Announces First Subjects Dosed in Phase I Clinical Trial for Lead Autoimmune/Inflammatory Disease Program ALPN-101
finance.yahoo.com - February 11 at 10:56 AM
Alpine Immune Sciences Inc.Alpine Immune Sciences Inc.
www.barrons.com - January 23 at 5:30 PM
Alpine Immune raises $25M via private placementAlpine Immune raises $25M via private placement
seekingalpha.com - January 16 at 9:25 AM
Alpine Immune Sciences Announces $25 Million Private PlacementAlpine Immune Sciences Announces $25 Million Private Placement
finance.yahoo.com - January 16 at 9:25 AM
Angion Completes Equity Financing and Appoints Senior ExecutivesAngion Completes Equity Financing and Appoints Senior Executives
finance.yahoo.com - January 4 at 4:57 PM
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel